Fulcrum Therapeutics, Inc.
Nasdaq: FULC
- Raised $68 million (2020)
- 10 clinical trials, 1 active
- Founded 2015
Life science companies
Explore 35,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Synlogic, Inc.
OTC: SYBX
- Raised $80 million (2019)
- 10 clinical trials
- Founded 2007
Perrigo Co
- 8 clinical trials
- FDA-cleared or approved devices
- 3 FDA-registered drug sites
TYBR Health, Inc.
- Raised $7.1 million (2025)
- FDA-cleared or approved devices
- Research grants: $1.6 million
- Founded 2020
Staar Surgical Co
Nasdaq: STAA
- 8 clinical trials, 2 active
- FDA-cleared or approved devices
Recombinetics, Inc
- Raised $7.7 million (2019)
- 2 FDA-registered drug sites
- Research grants: $17 million
Allogene Therapeutics, Inc.
Nasdaq: ALLO
- Raised $412 million (2018)
- 9 clinical trials, 5 active
- Founded 2017
Aura Biosciences, Inc.
Nasdaq: AURA
- Raised $80 million (2021)
- 9 clinical trials, 6 active
- Founded 2009
Carisma Therapeutics Inc.
OTC: CARM
- Raised $38 million (2021)
- 9 clinical trials
- Founded 2008
Creative Medical Technology Holdings, Inc.
Nasdaq: CELZ
- Raised $17 million (2022)
- 4 clinical trials, 3 active
EyePoint, Inc.
Nasdaq: EYPT
- Raised $16 million (2021)
- 19 clinical trials, 5 active
Harrow, Inc.
Nasdaq: HROW
- Raised $11 million (2021)
- 4 clinical trials, 2 active
Holobiome, Inc.
- Raised $6.6 million (2024)
- 1 clinical trial, 1 active
- Research grants: $3.9 million
- Founded 2015
Intellia Therapeutics, Inc.
Nasdaq: NTLA
- Raised $70 million (2015)
- 10 clinical trials, 7 active
- Founded 2014
Korro Bio, Inc.
Nasdaq: KRRO
- Raised $42 million (2020)
- 9 clinical trials, 1 active
- Founded 2014
LeonaBio, Inc.
Nasdaq: LONA
- Raised $89 million (2020)
- 9 clinical trials, 1 active
- Founded 2011
Leuko Labs, Inc.
- Raised $1.2 million (2019)
- 4 clinical trials, 1 active
- Research grants: $12 million
- Founded 2017
Perspective Therapeutics, Inc.
NYSE: CATX
- Raised $87 million (2024)
- 4 clinical trials, 3 active
Axsome Therapeutics, Inc.
Nasdaq: AXSM
- Raised $2.5 million (2015)
- 37 clinical trials, 12 active
- Founded 2012
Zeltiq Aesthetics Inc
- 39 clinical trials
- FDA-cleared or approved devices
Showing 640 of 35,266 companies
Load morePublished company profiles only; counts update daily. Data licences